AVE 20.0% 0.3¢ avecho biotechnology limited

the positive side if elixia launch ?fails?, page-19

  1. 379 Posts.
    Jev Thanks.

    I'm sorry I wasn't clear in my post. I entirely agree your point that POH neither would nor could show retailers' sales as its own. My point was simply that to generate the $700k bottom line, free cash to fund its other activities, POH would need sales amounting to several times that sum to be generated at retail level.
    How much that might be is pure guesswork but it would be 'a lot'.

    I hope the launch is as succesful as your predictions.
    It will be a considerable achievement if it gets near it.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(20.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $408 154.2K

Buyers (Bids)

No. Vol. Price($)
61 90794613 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 54998583 13
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.